What's New in Cryptococcus gattii: From Bench to Bedside and Beyond

Justin Beardsley1,2,3, Aiken Dao1,2,3, Caitlin Keighley1

  • 1Sydney Infectious Disease Institute, University of Sydney, Sydney, NSW 2145, Australia.

Insights

Cryptococcus gattii causes serious fungal infections, particularly in vulnerable individuals. This review covers the latest research on C. gattii, addressing its classification, spread, and treatment challenges.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Public Health

Background:

  • Cryptococcus species are significant causes of life-threatening infections.
  • Cryptococcus gattii is responsible for a substantial proportion of global cryptococcosis cases.
  • C. gattii infections have high early mortality rates (10-25%) despite optimal treatment.

Purpose of the Study:

  • To provide a comprehensive overview of Cryptococcus gattii infections.
  • To summarize recent advancements in understanding C. gattii.
  • To highlight the need for improved therapies and data for this medium-priority pathogen.

Main Methods:

  • This is a narrative review.
  • Literature search on taxonomy, epidemiology, pathogenesis, diagnostics, and management of C. gattii.
  • Synthesis of current research findings.

Main Results:

  • Cryptococcus gattii is a distinct species causing significant morbidity and mortality.
  • The World Health Organization has identified C. gattii as a medium-priority pathogen.
  • There is a critical need for more effective treatments and robust data.

Conclusions:

  • Cryptococcus gattii infections pose a significant global health challenge.
  • Further research is essential to improve diagnostic and therapeutic strategies.
  • Addressing data gaps is crucial for effective management of C. gattii.